Investment analysis, share recommendations, and market insights.
Michael Gable, Managing Director of Fairmont Equities, explains why Telix Pharmaceuticals (TLX) is trending higher again.
Are there any listed investment companies that just focus on resource stocks? What do the major brokers think of Woolworths? What are the limits in making super contributions this year? What are the best and worst performing industry sectors in 2026?
For the week ending Friday 26 June 2026, FNArena registered six upgrades for individual ASX-listed stocks, of which only half went to a Buy, and 11 downgrades, mostly to a Neutral/Hold rating.
I maintain that 'founder-led' companies make up a fascinating little cohort of the ASX and here are two great examples, in very different businesses, that appear to be good buying at current prices.
For our "HOT" stock today, Raymond Chan, Private Client Adviser and Head of Asian Desk notes that Morgans research team has added EVN to its Best Ideas list, supported by several key factors that he looks at in more detail.
You might hold an American Express Platinum card or be a platinum member of Qantas Frequent Flyers, but do you know that this metal is rarer than gold, harder than silver and has a rich story to tell. What's its future? Where can you buy it?
In my article today I'll test out whether you should get on board these rising stars.
Paul Rickard answers questions on SMSF borrowing, Transurban broker targets, Arafura Rare Earths share purchase plan, and APA Group's distribution reinvestment plan.
Michael Gable, Managing Director of Fairmont Equities, explains the bullish signs he's seeing for Codan (CDA).
My view is that investors should take a defensive stance and focus more on income investing to generate higher yield.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.